IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells
Molly D. Smithgall(Amgen (United States)), Dirk E. Smith(Amgen (United States)), Bo Ruem Yoon(Seoul National University), Richard Armitage(Amgen (United States)), Michael R. Comeau(Amgen (United States)), David R. Kaufman(Gates (United States))
Cited by 604
Related Papers
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
|Journal of Clinical Investigation|2017|3.9k
MHC class II–dependent basophil–CD4+ T cell interactions promote TH2 cytokine–dependent immunity
|Nature Immunology|2009|590
IL-1 family nomenclature
|Nature Immunology|2010|341
Emerging paradigms of cognition in medical decision-making
|Journal of Biomedical Informatics|2002|340